{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:24:57Z","timestamp":1780385097243,"version":"3.54.1"},"reference-count":122,"publisher":"Elsevier","isbn-type":[{"value":"9780128246221","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.acc.2020.09.006","type":"book-chapter","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T13:20:03Z","timestamp":1604150403000},"page":"299-340","source":"Crossref","is-referenced-by-count":28,"title":["Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2020.09.006_bb0010","first-page":"395","article-title":"Cryoglobulins: an important but neglected clinical test","volume":"36","author":"Shihabi","year":"2006","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0015","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","article-title":"Cryoglobulinemic vasculitis","volume":"42","author":"Lamprecht","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2020.09.006_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2007.02.019","article-title":"B-cells and mixed cryoglobulinemia","volume":"7","author":"Ferri","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2020.09.006_bb0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.imbio.2007.03.009","article-title":"Chronic helminth infections induce immunomodulation: consequences and mechanisms","volume":"212","author":"van Riet","year":"2007","journal-title":"Immunobiology"},{"key":"10.1016\/bs.acc.2020.09.006_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1196\/annals.1381.027","article-title":"Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience","volume":"1107","author":"Tervaert","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0040","first-page":"156","article-title":"Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud's disease","volume":"52","author":"Wintrobe","year":"1933","journal-title":"Bull. John Hopkins Hosp."},{"key":"10.1016\/bs.acc.2020.09.006_bb0045","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00000441-194710000-00009","article-title":"Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin)","volume":"214","author":"Lerner","year":"1947","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(62)90191-2","article-title":"Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin","volume":"32","author":"Lospalluto","year":"1962","journal-title":"Am. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins: a report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0060","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0002-9343(66)90199-9","article-title":"Cryoglobulinemia: a study of 29 patients","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0065","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4049\/jimmunol.140.4.1218","article-title":"Electrostatic properties of cryoimmunoglobulins","volume":"140","author":"Lawson","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1258\/acb.2009.009180","article-title":"Cryoglobulin evaluation: best practice?","volume":"47","author":"Sargur","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002281-200001000-00009","article-title":"Relation between infection and autoimmunity in mixed cryoglobulinemia","volume":"12","author":"Ferri","year":"2000","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0085","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/clinchem\/38.6.798","article-title":"Characterization of cryoglobulins by immunoblotting","volume":"38","author":"Musset","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0090","first-page":"693","article-title":"Clinical implications of the types of cryoglobulins determined by two dimensional polyacrylamide gel electrophoresis","volume":"83","author":"Tissot","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/bs.acc.2020.09.006_bb0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ajh.22023","article-title":"Laboratory testing for cryoglobulins","volume":"86","author":"Motyckova","year":"2011","journal-title":"Am. J. Hematol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0100","first-page":"287","article-title":"Biclonal immunoglobulin M dysglobulinaemia: evolving aspects in a case of primary Sjogren syndrome","volume":"35","author":"Pontet","year":"1997","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0105","first-page":"55","article-title":"Cryoglobulinemies: proposition d'un protocole d'exploration biologique. Actualisation de leur classification","volume":"221","author":"Le Carrer","year":"1998","journal-title":"Feuillets Boil."},{"key":"10.1016\/bs.acc.2020.09.006_bb0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"Cryoglobulinemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2020.09.006_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.dld.2017.06.003","article-title":"IgG3 sub-class: a possible trigger of mixed cryoglobulin cascade in hepatitis C viruschronic infection","volume":"49","author":"Basile","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/bs.acc.2020.09.006_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0161-5890(78)90146-3","article-title":"Molecular basis of the temperature-dependent insolubility of cryoglobulins. IV. Structural studies of the IgM monoclonal cryoglobulin","volume":"15","author":"Middaugh","year":"1987","journal-title":"Immunochemistry"},{"key":"10.1016\/bs.acc.2020.09.006_bb0125","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood.V97.11.3537","article-title":"Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins","volume":"97","author":"Mizuochi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2020.09.006_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(80)90781-3","article-title":"Nature of cryoglobulinemia","volume":"1","author":"Levo","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2020.09.006_bb0135","article-title":"Cryoglobulin test and cryoglobulinemia hepatitis C-virus related","volume":"9","author":"Gulli","year":"2017","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/bs.acc.2020.09.006_bb0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V69.2.677.677","article-title":"Characterization of monoclonal IgG cryoglobulins: fine-structural and morphological analysis","volume":"69","author":"Podell","year":"1987","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2020.09.006_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","article-title":"Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection","volume":"11","author":"Zignego","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/bs.acc.2020.09.006_bb0155","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1515\/cclm-2015-0404","article-title":"Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport","volume":"54","author":"Basile","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5858\/1999-123-0119-EOC","article-title":"Evaluation of cryoglobulins","volume":"123","author":"Kallemuchikkal","year":"1999","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0165","doi-asserted-by":"crossref","first-page":"783063","DOI":"10.1155\/2015\/783063","article-title":"Comparison between the traditional and a rapid screening test for cryoimmunoglobulins detection","volume":"2015","author":"Romitelli","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/bs.acc.2020.09.006_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/CCLM.2003.015","article-title":"Adequate sampling in cyioglobulinaemia: recommended warmly","volume":"41","author":"Bakker","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22027","article-title":"Comparison of fully automated and semiautomated systems for protein immunofixation electrophoresis","volume":"31","author":"Napodano","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/bs.acc.2020.09.006_bb0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/bs.acc.2020.09.006_bb0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.2016.2240","article-title":"Biomarkers and surrogate endpoints: developing common terminology and definitions","volume":"315","author":"Robb","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2020.09.006_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/bs.acc.2020.09.006_bb0195","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.autrev.2019.03.003","article-title":"Free light chains and autoimmunity","volume":"18","author":"Napodano","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2020.09.006_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/cei.13385","article-title":"Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases","volume":"199","author":"Gulli","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nyas.13562","article-title":"Rituximab in myasthenia gravis: a \u201cto be or not to be\u201d inhibitor of T cell function","volume":"1413","author":"Marino","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0210","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/liv.12829","article-title":"Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment","volume":"35","author":"Basile","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/bs.acc.2020.09.006_bb0215","article-title":"Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia","author":"Basile","year":"2020","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0220","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fimmu.2020.00613","article-title":"Long-lasting rituximab-induced reduction of specific-but not total-IgG4 in MuSK-positive myasthenia gravis","volume":"11","author":"Marino","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/08820139.2019.1637434","article-title":"The laboratory role in anti-TNF biological therapy era","volume":"49","author":"Grossi","year":"2020","journal-title":"Immunol. Invest."},{"issue":"5","key":"10.1016\/bs.acc.2020.09.006_bb0230","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.autrev.2016.01.012","article-title":"Long term outcome of patients with low level of cryoglobulin (<0.05g\/L)","volume":"15","author":"Eble","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2020.09.006_bb0235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/biof.1485","article-title":"Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins","volume":"45","author":"Basile","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/bs.acc.2020.09.006_bb0240","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0245","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7754\/Clin.Lab.2017.171043","article-title":"Subclasses of monoclonal (type I) immunoglobulin G cryoglobulins: report on two distinct cases with myeloma","volume":"64","author":"Petersen","year":"2018","journal-title":"Clin. Lab."},{"key":"10.1016\/bs.acc.2020.09.006_bb0250","first-page":"6057","article-title":"IgG cryoglobulinemia","volume":"22","author":"Gulli","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0255","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/bmj.2.5757.322","article-title":"IgG subclasses in relation to viscosity and cryoglobulin syndromes","volume":"2","author":"Virella","year":"1971","journal-title":"Br. Med. J."},{"key":"10.1016\/bs.acc.2020.09.006_bb0260","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1136\/ard.52.Suppl_1.S48","article-title":"IgG3 cryoglobulins in autoimmune MRL-Ipr\/Iprl mice: immunopathogenesis, theurapetic approaches and relevance to similar human diseases","volume":"52","author":"Izui","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2020.09.006_bb0265","first-page":"405","article-title":"IgG heavy chain sub-classes in mixed cryoglobulins","volume":"23","author":"Cream","year":"1972","journal-title":"Immunology"},{"key":"10.1016\/bs.acc.2020.09.006_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2249.1996.d01-639.x","article-title":"Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection","volume":"104","author":"Wong","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0275","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0168-8278(98)80114-1","article-title":"Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications","volume":"29","author":"Mondelli","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.dld.2014.09.010","article-title":"Anti-nuclear antibody detection in cryoprecipitates: distinctive patterns in hepatitis C virus-infected patients","volume":"47","author":"Basile","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/bs.acc.2020.09.006_bb0285","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.dld.2016.05.013","article-title":"Autoimmunity and lymphoproliferation markers in na\u00efve HCV-RNA positive patients without clinical evidences of autoimmune\/lymphoproliferative disorders","volume":"48","author":"Gulli","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/bs.acc.2020.09.006_bb0290","first-page":"480","article-title":"Rheumatoid factors in hepatitis B and C infections: connecting viruses, autoimmunity, and cancer","volume":"21","author":"Moll","year":"2019","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/bs.acc.2020.09.006_bb0295","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/bs.acc.2020.09.006_bb0300","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2017.11.035","article-title":"Cryoglobulins: an update on detection, mechanisms and clinical contribution","volume":"17","author":"Kolopp-Sarda","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2020.09.006_bb0305","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.081035","article-title":"Observations on cryoglobulin testing: I. The association of cryoglobulins containing rheumatoid factors with manifestation of cryoglobulinemic vasculitis","volume":"36","author":"De Rosa","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0310","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.1780401113","article-title":"Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia","volume":"40","author":"Agnello","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2020.09.006_bb0315","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fimmu.2018.01001","article-title":"The complement system and C1q in chronic hepatitis C virus infection and mixed cryoglobulinemia","volume":"9","author":"El-Shamy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2016.07.023","article-title":"The Kunkel legacy and hepatitis C virus infection","volume":"172","author":"Agnello","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0325","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02828280","article-title":"Mixed cryoglobulinemia as a model of systemic vasculitis","volume":"15","author":"Dammacco","year":"1997","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/bs.acc.2020.09.006_bb0330","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.160.7.3594","article-title":"Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia","volume":"160","author":"Sansonno","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0335","first-page":"S101","article-title":"The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia","volume":"13","author":"Agnello","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0340","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/art.27490","article-title":"Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies","volume":"62","author":"Knight","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.acc.2020.09.006_bb0345","first-page":"102","article-title":"How immunological profile drives clinical phenotype of primary Sj\u00f6gren's syndrome at diagnosis: analysis of 10,500 patients (Sj\u00f6gren Big Data Project)","volume":"112","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0350","first-page":"234","article-title":"Serum cryoglobulins and disease activity in systematic lupus erythematosus","volume":"18","author":"Karimifar","year":"2013","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0355","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2020.09.006_bb0360","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/bs.acc.2020.09.006_bb0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0162-3109(00)80301-X","article-title":"C1q: structure, function, and receptors","volume":"49","author":"Kishore","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/bs.acc.2020.09.006_bb0370","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1172\/JCI105541","article-title":"Studies of cryoproteins in systemic lupus erythematosus","volume":"46","author":"Hanauer","year":"1967","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2020.09.006_bb0375","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2249.2003.02204.x","article-title":"Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia","volume":"133","author":"Sansonno","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0380","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0385","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CBF.S57681","article-title":"Polyclonal free light chains: promising new biomarkers in inflammatory disease","volume":"4","author":"Hampson","year":"2014","journal-title":"Curr. Biomark. Find."},{"key":"10.1016\/bs.acc.2020.09.006_bb0390","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2017.09.005","article-title":"Free light chains: eclectic multipurpose biomarker","volume":"451","author":"Basile","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/bs.acc.2020.09.006_bb0395","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"IMWG updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejphar.2005.12.065","article-title":"Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases","volume":"533","author":"van der Heijden","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0405","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.biopha.2017.04.121","article-title":"The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases","volume":"91","author":"Esparvarinha","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/bs.acc.2020.09.006_bb0410","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1471-4906(03)00059-0","article-title":"Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?","volume":"24","author":"Redegeld","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0415","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nm722","article-title":"Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses","volume":"8","author":"Redegeld","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0420","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.153.11.5121","article-title":"Proteolytic activity of an antibody light chain","volume":"153","author":"Sun","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0425","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.1074\/jbc.270.25.15257","article-title":"Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment","volume":"270","author":"Paul","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0430","first-page":"282","article-title":"Immunoglobulin free light chains in the pathogenesis of lung disorders","volume":"16","author":"Mortaz","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0435","doi-asserted-by":"crossref","first-page":"9646209","DOI":"10.1155\/2018\/9646209","article-title":"Serological immunoglobulin-free light chain profile in myasthenia gravis patients","volume":"2018","author":"Basile","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/bs.acc.2020.09.006_bb0440","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/bs.acc.2020.09.006_bb0445","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/ard.2007.086488","article-title":"Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders","volume":"68","author":"Terrier","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/bs.acc.2020.09.006_bb0450","doi-asserted-by":"crossref","first-page":"112687","DOI":"10.1016\/j.jim.2019.112687","article-title":"Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia","volume":"476","author":"Basile","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/bs.acc.2020.09.006_bb0455","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa\/lambda ratios","volume":"55","author":"Bradwell","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinbiochem.2016.11.007","article-title":"IgMk-IgM\u03bb pair quantitation in the clinical laboratory practice","volume":"51","author":"Sarto","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2020.09.006_bb0465","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3109\/10428194.2013.767456","article-title":"Immunoglobulin heavy chain\/light chain pair measurement is associated with survival in diffuse large Bcell lymphoma","volume":"54","author":"Jardin","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/bs.acc.2020.09.006_bb0470","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/10428194.2019.1706731","article-title":"The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL)","volume":"61","author":"Maiolo","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/bs.acc.2020.09.006_bb0475","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.autrev.2013.11.001","article-title":"Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection","volume":"13","author":"Terrier","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2020.09.006_bb0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7827-2-3","article-title":"Syndecans in tumor cell adhesion and signaling","volume":"2","author":"Beauvais","year":"2004","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1126\/scisignal.264pe18","article-title":"Syndecans shed their reputation as inert molecules","volume":"2","author":"Bass","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/bs.acc.2020.09.006_bb0490","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ar.20757","article-title":"Molecular and cellular mechanisms of ectodomain shedding","volume":"293","author":"Hayashida","year":"2010","journal-title":"Anat. Rec. (Hoboken)"},{"issue":"1","key":"10.1016\/bs.acc.2020.09.006_bb0495","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13046-015-0155-4","article-title":"Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies","volume":"34","author":"Cigliana","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2020.09.006_bb0500","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","article-title":"Serum syndecan-1: a new independent prognostic marker in multiple myeloma","volume":"95","author":"Seidel","year":"2000","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2020.09.006_bb0505","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1128\/JVI.03475-12","article-title":"Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes","volume":"87","author":"Shi","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0510","first-page":"4293","article-title":"A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders","volume":"23","author":"Basile","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0515","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1478-3231.2008.01830.x","article-title":"Syndecan1 (SCD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C","volume":"29","author":"Zvibel","year":"2009","journal-title":"Liver Int."},{"issue":"15","key":"10.1016\/bs.acc.2020.09.006_bb0520","first-page":"8067","article-title":"Biomarkers in HCV related mixed cryoglobulinemia patients with non-hodgkin lymphoma","volume":"24","author":"Gulli","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/bs.acc.2020.09.006_bb0525","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0530","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2009.247","article-title":"Hepatitis C virus-induced cryoglobulinemia","volume":"76","author":"Charles","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/bs.acc.2020.09.006_bb0535","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","article-title":"Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2020.09.006_bb0540","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21\u2212 human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2020.09.006_bb0545","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.acc.2020.09.006_bb0550","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/eji.201142313","article-title":"Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21(low) cells overexpressing Stra13","volume":"42","author":"Visentini","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0555","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20050879","article-title":"Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells","volume":"202","author":"Ehrhardt","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0560","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0565","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2017-03-771238","article-title":"Reversion of anergy signatures in clonal CD21low B-cells of mixed cryoglobulinemia after clearance of HCV viremia","volume":"130","author":"Del Padre","year":"2017","journal-title":"Blood"},{"key":"10.1016\/bs.acc.2020.09.006_bb0570","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/liv.14053","article-title":"Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis","volume":"39","author":"Visentini","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/bs.acc.2020.09.006_bb0575","doi-asserted-by":"crossref","first-page":"102313","DOI":"10.1016\/j.jaut.2019.102313","article-title":"New insights in cryoglobulinemic vasculitis","volume":"105","author":"Silva","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/bs.acc.2020.09.006_bb0580","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ekir.2019.04.022","article-title":"Persistent mixed cryoglobulinemia despite successful treatment of hepatitis C, aggressive B-cell-directed therapies, and long-term plasma exchanges","volume":"4","author":"Pelletier","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/bs.acc.2020.09.006_bb0585","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1208642","article-title":"Therapy for hepatitis C virus-related cryoglobulinemic vasculitis","volume":"369","author":"Dammacco","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2020.09.006_bb0590","doi-asserted-by":"crossref","first-page":"102589","DOI":"10.1016\/j.autrev.2020.102589","article-title":"Hepatitis C virus-related cryoglobulinemic vasculitis: a review of the role of the new direct antiviral agents (DAAs) therapy","volume":"19","author":"Mazzaro","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/bs.acc.2020.09.006_bb0595","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.gastro.2018.04.024","article-title":"Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure","volume":"155","author":"Bonacci","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acc.2020.09.006_bb0600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ekir.2016.06.006","article-title":"Lupus-like immune complex-mediated glomerulonephritis in patients with hepatitis C virus infection treated with oral, interferon-free, direct-acting antiviral therapy","volume":"1","author":"Sise","year":"2016","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/bs.acc.2020.09.006_bb0605","doi-asserted-by":"crossref","first-page":"108487","DOI":"10.1016\/j.clim.2020.108487","article-title":"Type 3 hypersensitivity in COVID-19 vasculitis","volume":"217","author":"Roncati","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/bs.acc.2020.09.006_bb0610","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2020.09.006_bb0615","article-title":"Cryoglobulins: putative effectors of adaptive immune response","author":"Basile","year":"2020","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242320301268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242320301268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:41:15Z","timestamp":1758742875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242320301268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128246221"],"references-count":122,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2020.09.006","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}